pharma · No medical condition. · Breast cancer
George Institute for
The George Institute
George Institute is a pharma organization headquartered in KOLKATA, IN. Primary therapeutic focus areas include No medical condition., Breast cancer, Metastatic colorectal cancer, Prostate Cancer, advanced/metastatic HER
Sydney, NSW 2042, AU HQ
1999 Founded
841 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Sydney, NSW 2042, AU
- Founded
- 1999
- Employees
- 841
- Programs
- 406
- Drugs
- 522
- Patents
- 0
U1111-1305-0044
Phase 2 · other · Early triple-negative breast cancer (TNBC)
U1111-1305-0044 for Early triple-negative breast cancer (TNBC) is a Phase 2 program (other) at The George Institute with 1 ClinicalTrials.gov record(s).
Internal code U1111-1305-0044
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- The George Institute
- Phase
- Phase 2
- Modality
- other
- Indication
- Early triple-negative breast cancer (TNBC)
- Status
- active
- Trials
- 1